
Veeva Systems (VEEV) Stock
Cloud software platform for pharmaceutical and biotech firms. Here's the price, business snapshot, and what's worth knowing about Veeva Systems in November 2026.
Veeva Systems (VEEV) is a cloud‑software company focused on the life sciences industry, providing CRM, clinical, regulatory, quality and data platforms designed for pharmaceutical, biotech and medical‑device firms. It operates a subscription‑based model with high recurring revenue, which has supported steady margins and cash generation as the sector digitises. Key growth drivers include continued R&D outsourcing, regulatory complexity that favours specialised vendors, international expansion and cross‑selling of new modules to existing customers. Investors should note Veeva’s exposure to the healthcare sector and customer concentration in large pharma, which can amplify cyclicality. The shares currently reflect a premium for software‑like margins and growth; valuation and future revenue growth are important to watch. This is general information, not personal financial advice — returns can be volatile and past performance is not a guarantee. Consider whether the company’s sector concentration and valuation fit your risk tolerance and investment horizon.
Why It’s Moving

Veeva Shares Dip Amid Broader Market Volatility as Earnings Date Looms
- Stock closed at $289.64, marking a -3.22% move from the previous day and underperforming the wider market.
- Company confirmed it will announce financial results for the quarter ending October 31, 2026, after market close on December 3, 2026.
- Despite the recent dip, Veeva was cited as a top contributor to the Thrivent Mid Cap Stock Fund’s Q3 performance relative to its detractors.

Veeva Shares Dip Amid Broader Market Volatility as Earnings Date Looms
- Stock closed at $289.64, marking a -3.22% move from the previous day and underperforming the wider market.
- Company confirmed it will announce financial results for the quarter ending October 31, 2026, after market close on December 3, 2026.
- Despite the recent dip, Veeva was cited as a top contributor to the Thrivent Mid Cap Stock Fund’s Q3 performance relative to its detractors.
Six-Month Growth Performance
When is the next earnings date for VEEVA SYSTEMS INC (VEEV)?
Veeva Systems is scheduled to release its next earnings report on December 3, 2026, after market closes. This upcoming announcement will cover the company's fiscal third quarter results for the period ending in late November 2026. Investors should note that this date follows the confirmed reporting pattern observed in recent quarters, maintaining consistency with prior disclosure timelines.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Veeva Systems stock with a target price of $292.9, indicating growth potential.
Financial Health
Veeva Systems is performing well with strong profits, revenue, and cash flow generation.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Recurring revenue model
Subscription contracts create predictable revenue and strong margins, though future growth depends on new customer wins and cross‑selling to existing clients.
Global pharma footprint
Veeva benefits from long relationships with major pharmaceutical companies and international expansion, but customer concentration can increase sector sensitivity.
Product innovation focus
Ongoing investment in specialised modules and data services supports cross‑sell opportunities, though competition and regulatory changes can affect adoption rates.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.